Research field (4)：
Immunology
, Hematology and oncology
, Tumor diagnostics and therapeutics
, Tumor biology
Research theme for competitive and other funds (5)：
2023 - 2025 Establishment of a platform for high-throughput CAR-T cell generation for gastric cancer
2022 - 2025 Development of novel cancer immunotherapies targeting functional MDSCs
2020 - 2023 「無細胞タンパク質合成系を用いた抗体作成」による免疫関連有害事象の病態解明
2018 - 2021 Identification of responder of gastric cancer patients for anti-PD-1 antibody therapy by quantification the capacity of CD28 molecules on the surface of T cells.
2018 - 2021 Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research
Papers (72)：
Yasuyuki Saito, Rie Iida-Norita, Tania Afroj, Alaa Refaat, Daisuke Hazama, Satomi Komori, Shinya Ohata, Tomoko Takai, Okechi S. Oduori, Takenori Kotani, et al. Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models. Frontiers in Immunology. 2023. 14
Yuhi Shimura, Shohei Komatsu, Yoshiaki Nagatani, Yohei Funakoshi, Keitaro Sofue, Masahiro Kido, Kaori Kuramitsu, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, et al. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases. Annals of surgical oncology. 2023. 30. 11. 6603-6610
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Wataru Hojo, Hironori Sakai, Sakuya Matsumoto, Marika Watanabe, Akihito Kitao, Yasuyuki Saito, et al. Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration. British journal of haematology. 2023. 202. 3. 504-516
Megumi Nishikubo, Yugo Tanaka, Suguru Mitsui, Takefumi Doi, Daisuke Hokka, Wataru Hojo, Hironori Sakai, Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al. Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy. Surgery today. 2023. 1-7
Yasunori Fujita, Fumika Kamitani, Masaaki Yamamoto, Hidenori Fukuoka, Yushi Hirota, Nobuharu Nishiyama, Naho Goda, Yuko Okada, Yuiko Inaba, Hiroki Nakajima, et al. Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors. Journal of the Endocrine Society. 2023. 7. 3. bvad002
Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody
(63rd ASH Annual Meeting 2021)
Relationship between tumor burden to growth rate and treatment outcomes of nivolumab for patients with head and neck squamous carcinoma.
(ASCO-SITC 2019)
TP-0903, a multikinase inhibitor of AXL/JAK2/Aurora B, reduces inflammatory breast
(2018San Antonio Breast Cancer Symposium 2018)
